The Research and Development team at Astria Therapeutics focuses on innovating and advancing therapies for hereditary angioedema (HAE) and rare allergic and immunological diseases. Comprised of experts in chemistry, biology, and antibody discovery, the team collaborates to design, develop, and optimize potential treatments, ensuring their safety and efficacy for patients. Each member plays a crucial role in driving scientific excellence and pushing the boundaries of therapeutic innovation.
View all